Latest News about BHVN
Recent news which mentions BHVN
From Benzinga
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
May 29, 2024
From Benzinga
From Benzinga
What's Going On With Biohaven Stock Wednesday?
May 29, 2024
From Benzinga
From Benzinga
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
From Benzinga
Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
May 14, 2024
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
3 Biotech Stocks to Buy on the Dip: April 2024
April 26, 2024
From InvestorPlace
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
From Benzinga
From Benzinga
From Benzinga
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
From Benzinga
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
January 25, 2024
From InvestorPlace
FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
December 20, 2023
From Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
September 29, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 27, 2023
From Benzinga
What's Going On Pfizer's Subsidiary Biohaven Stock?
September 27, 2023
From Benzinga
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 27, 2023
From Benzinga
MillerKnoll, Hayward Holdings, Ginkgo Bioworks And Other Big Stocks Moving Higher On Wednesday
September 27, 2023
From Benzinga
US Stocks Open Higher; Costco Posts Upbeat Earnings
September 27, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 27, 2023
From Benzinga
Cramer Warns Investors About This AI Company Up 146% YTD: 'Too Much Hype, Too Much Fluff'
September 20, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.